Regarding current diabetes medication, 74 participants (49.3%) were on oral hypoglycaemics, 43 (28.7%) were on both oral hypoglycaemics and insulin, and 33 (22%) were on insulin only (Table 2). The gene discussed is INS; the disease is diabetes mellitus.